The abnormal brain accumulation of amyloid-beta (Aβ) proteins and intraneuronal neurofibrillary tangles of tau proteins, as well as neuroinflammation, are the key pathogenic events in the development and progression of AD (Ising et al., 2019). The gene discussed is MAPT; the disease is Alzheimer disease.